To the Editor: Te Marvelde and colleagues1 report that patients with prostate cancer diagnosed in the private health system in Victoria are more likely to undergo radical treatment than patients in the public system. In particular, they report that patients in the private system undergo surgery more often than those in the public system (44% v 28%; odds ratio, 2.28; 95% CI, 2.13–2.44). The authors do not provide an explanation for this, but the inference is that private patients may be more likely to be overtreated in private hospitals. We respectfully point out two more plausible explanations.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Te Marvelde L, Milne RL, Hornby CJ, et al. Differences in treatment choices for localised prostate cancer diagnosed in private and public health services. Med J Aust 2020; 213: 411–417. https://www.mja.com.au/journal/2020/213/9/differences-treatment-choices-localised-prostate-cancer-diagnosed-private-and
- 2. Evans SM, Millar JL, Davis ID, et al. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust 2013; 198: 540–545. https://www.mja.com.au/journal/2013/198/10/patterns-care-men-diagnosed-prostate-cancer-victoria-2008-2011
- 3. Wang LL, Begashaw K, Evans M, et al. Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update. ANZ J Surg 2018; 88: 1037–1042.
- 4. Sampurno F, Earnest A, Kumari PB, et al. Quality of care achievements of the Prostate Cancer Outcomes Registry‐Victoria. Med J Aust 2016; 204: 319. https://www.mja.com.au/journal/2016/204/8/quality-care-achievements-prostate-cancer-outcomes-registry-victoria
- 5. Evans SM, Millar JL, Frydenberg M, et al. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry. BJU Int 2014; 114: 680–690.
- 6. MacKee N. Radical prostate cancer treatment more frequent in private system. MJA InSight+ 2020; 12 Oct. https://insightplus.mja.com.au/2020/40/radical-prostate-cancer-treatment-more-frequent-in-private-system/ (viewed Nov 2020).
- 7. Glasziou PP, Jones MA, Pathirana T, et al. Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust 2020; 212: 163–168. https://www.mja.com.au/journal/2020/212/4/estimating-magnitude-cancer-overdiagnosis-australia
- 8. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI‐targeted or standard biopsy for prostate‐cancer diagnosis. N Engl J Med 2018; 378: 1767–1777.
No relevant disclosures.